Insider Trading activities at Landos Biopharma, Inc. (LABP)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Landos Biopharma, Inc. (LABP) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Landos Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1785345.

Total stock buying since 2021: $59,515,008.
Total stock sales since 2021: $3,074,321.
Total stock option exercises since 2021: $219,580.


5 insiders reported insider trading activities at Landos Biopharma, Inc. (LABP):
Insider trading activities of Wong Roderick
Insider trading activities of Edelman Joseph
Insider trading activities of Poukalov Konstantin
Insider trading activities of Chauhan Jyoti
Insider trading activities of Bassaganya-riera Josep

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Landos Biopharma, Inc. (LABP).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 0 $0 5,720,868 $0 0 $0
2021 3,871,480 $59,515,008 521,715 $3,074,321 118,054 $219,580

Table 2. Monthly summary of insider trading at Landos Biopharma, Inc. (LABP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-02 0 $0 5,720,868 $0 0 $0
2021-12 0 $0 471,285 $2,710,269 0 $0
2021-11 0 $0 50,430 $364,052 0 $0
2021-07 0 $0 0 $0 118,054 $219,580
2021-02 3,871,480 $59,515,008 0 $0 0 $0

Table 3. Detailed insider trading at Landos Biopharma, Inc. (LABP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-02-28 Bassaganya-riera Josep (10% Owner) Sale 5,720,868 .00 0
2021-12-20 Bassaganya-riera Josep (10% Owner) Sale 33,194 4.75 157,804
2021-12-17 Bassaganya-riera Josep (10% Owner) Sale 36,000 4.84 174,096
2021-12-16 Bassaganya-riera Josep (10% Owner) Sale 24,301 5.11 124,251
2021-12-15 Bassaganya-riera Josep (10% Owner) Sale 43,000 5.02 216,032
2021-12-14 Bassaganya-riera Josep (10% Owner) Sale 42,000 5.10 214,284
2021-12-13 Bassaganya-riera Josep (10% Owner) Sale 40,000 5.37 214,840
2021-12-10 Bassaganya-riera Josep (10% Owner) Sale 40,000 5.77 230,799
2021-12-09 Bassaganya-riera Josep (10% Owner) Sale 11,162 6.26 69,829
2021-12-08 Bassaganya-riera Josep (10% Owner) Sale 25,530 6.65 169,723
2021-12-07 Bassaganya-riera Josep (10% Owner) Sale 42,000 6.58 276,528
2021-12-06 Bassaganya-riera Josep (10% Owner) Sale 36,000 6.17 221,976
2021-12-03 Bassaganya-riera Josep (10% Owner) Sale 36,000 6.15 221,364
2021-12-02 Bassaganya-riera Josep (10% Owner) Sale 29,861 6.45 192,633
2021-12-01 Bassaganya-riera Josep (10% Owner) Sale 32,237 7.01 226,110
2021-11-30 Bassaganya-riera Josep (10% Owner) Sale 35,000 7.06 247,170
2021-11-29 Bassaganya-riera Josep (10% Owner) Sale 15,430 7.58 116,882
2021-07-26 Chauhan Jyoti (ED, Global Clinical Operations) Option Ex 118,054 1.86 219,580
2021-02-09 Poukalov Konstantin (Director) Buy 99,681 14.20 1,415,470
2021-02-09 Edelman Joseph (Director) Buy 99,681 14.20 1,415,470
2021-02-08 Poukalov Konstantin (Director) Buy 1,373,053 14.17 21,518,104
2021-02-08 Edelman Joseph (Director) Buy 1,373,053 14.17 21,518,104
2021-02-05 Poukalov Konstantin (Director) Buy 27,453 11.14 305,826
2021-02-05 Edelman Joseph (Director) Buy 27,453 11.14 305,826
2021-02-04 Wong Roderick Buy 625,000 16.00 10,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of LABP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Landos Biopharma, Inc. (symbol LABP, CIK number 1785345) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.